Showing 696 results
-
Media Release /- Brolucizumab, the first and only anti-VEGF to maintain a majority of patients on a 12-week treatment schedule immediately following loading phase in Phase III trials, met primary endpoint of non-…
-
Media Release /
-
Media Release /- Structural joint damage in psoriatic arthritis (PsA) patients taking Cosentyx® (secukinumab) was inhibited at 24 weeks versus placebo in all arms of the study(1)- PsA can lead to reduced mobility…
-
Media Release /
-
Media Release /- Primary results of pivotal Kymriah™ Phase II JULIET study in relapsed/refractory DLBCL- Post-hoc sub-analysis of crizanlizumab (SEG101, formerly SelG1) SUSTAIN trial evaluating time to first sickle…
-
Media Release /
-
Media Release /- PARADIGMS data also show fingolimod-treated patients had significantly fewer new brain lesions vs. those on intramuscular interferon beta-1a injections(1)- Currently there are no disease-modifying…
-
Media Release /
-
Media Release /
Novartis collaborates with pop icon Cyndi Lauper to release new song in honor of World Psoriasis Day
- "Hope" is inspired by the psoriasis community and Lauper's own experience living with the disease- Song and music video are available to stream at SEEMEtoknow.com- An estimated 7.5 million people… -
Media Release /
